@article{2abcfb37352d440786bdd8b26800e814,
title = "Protease inhibitors do not affect antibody responses to pneumococcal vaccination",
abstract = "HIV+ subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination.",
author = "{De La Rosa}, Indhira and Munjal, {Iona M.} and Maria Rodriguez-Barradas and Xiaoying Yu and Pirofski, {Liise Anne} and Daniel Mendoza",
note = "Funding Information: This work, including the efforts of Liise-anne Pirofski, was funded by HHS | National Institutes of Health (NIH) (R01AG045044). This work, including the efforts of Liise-anne Pirofski, was funded by HHS | National Institutes of Health (NIH) (R56AI104234). This work, including the efforts of Daniel Mendoza, was funded by American Association of Immunologists (AAI). Publisher Copyright: Copyright {\textcopyright} 2016, American Society for Microbiology. All Rights Reserved.",
year = "2016",
month = jun,
doi = "10.1128/CVI.00026-16",
language = "English (US)",
volume = "23",
pages = "524--529",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "6",
}